StockWatch
·
Commodity Chemicals
Board Meeting13 Nov 2026, 02:41 pm

Kanoria Chemicals: consolidated PAT ₹22.7 Cr as core business turns profitable YoY

AI Summary

Kanoria Chemicals' consolidated PAT was ₹22.72 Cr for Q2 FY27 (quarter ended 30 September 2026), on revenue from operations of ₹357.98 Cr, up 70.6% YoY from ₹209.84 Cr. Reported consolidated PAT looks like a 75.3% YoY decline against last year's ₹91.81 Cr, but that figure is inflated by a ₹97.66 Cr one-off gain on loss of control of a discontinued subsidiary booked in Q2 FY26; stripping it out, continuing operations swung from a ₹2.24 Cr loss a year ago to this quarter's ₹22.72 Cr profit — the core-business turnaround the company itself highlighted in its results disclosure. Standalone PAT, which was never affected by that subsidiary, confirms the cleaner read: it grew 258% YoY to ₹23.27 Cr from ₹6.50 Cr, diverging sharply from the consolidated headline purely because of last year's one-off, not weaker underlying performance. Sequentially, revenue eased 22.2% from Q1 FY27's ₹460.37 Cr and PAT was down 13.8% from ₹26.36 Cr — a pull-back after a strong first quarter rather than a change in trend. EBITDA margin improved to roughly 12.9% of revenue this quarter from about 8.8% a year ago on a continuing-operations basis, while net margin moved from a negative base to roughly 6.3%, consistent with the swing to profit; sequentially, margins held broadly steady versus Q1 FY27 (reported OPM 9.78%, NPM 5.64%). There is no prior management guidance or outlook on record for this company, and no formal analyst/street estimate for Q2 FY27 could be located in public sources, so the print cannot be benchmarked against either; management's press release accompanying this filing was also not available for review. On the corporate side, the same board meeting approved re-appointing Rajya Vardhan Kanoria as Managing Director for a further three years from 10 January 2027, and the quarter follows the October 2026 commissioning of a new 12 TPD Triacetin facility — a plausible, though filing-unconfirmed, contributor to the YoY revenue growth. The sole subsidiary, Kanoria Africa Textiles (Ethiopia), remains small: ₹30.71 Cr of pre-consolidation quarterly revenue and a ₹0.55 Cr loss, so standalone and consolidated PAT (₹23.27 Cr vs ₹22.72 Cr) stay close this quarter.

Key Highlights

  • Consolidated PAT ₹22.72 Cr vs a ₹2.24 Cr loss from continuing operations in Q2 FY26 — core business turns profitable YoY
  • Reported consolidated PAT down 75.3% YoY (₹22.72 Cr vs ₹91.81 Cr) only because Q2 FY26 included a ₹97.66 Cr one-off gain on loss of control of a discontinued subsidiary
  • Standalone PAT up 258% YoY to ₹23.27 Cr from ₹6.50 Cr — the cleaner, subsidiary-unaffected read confirming genuine growth
  • Consolidated revenue ₹357.98 Cr, +70.6% YoY, but -22.2% QoQ from Q1 FY27's ₹460.37 Cr
  • EBITDA margin ~12.9% this quarter vs ~8.8% a year ago (continuing ops) — margin expansion
  • EPS ₹5.20 (continuing & discontinued combined) vs ₹(0.51) YoY (continuing ops) and ₹6.03 in Q1 FY27
  • Board separately approved re-appointment of Rajya Vardhan Kanoria as MD for 3 years from 10 Jan 2027